Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31 Mar 2026 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 30 Sept 2024 |
|---|---|---|---|---|---|
| Research and development | 901,144 | 619,693 | 651,784 | — | — |
| Selling, general and administrative | 11M | 1M | 2M | 364,368 | 299,999 |
| Operating expenses | 12M | 2M | 3M | 364,368 | 299,999 |
| Operating income | −12M | −2M | −3M | −364,368 | −299,999 |
| Net income | −35M | −2M | −3M | −402,397 | −332,521 |
| Earnings per share | −2.26 | −0.14 | −0.26 | −0.05 | −0.04 |
| Earnings per share, diluted | −2.26 | −0.14 | −0.26 | −0.05 | −0.04 |
| Weighted average shares | 16M | 13M | 10M | 8M | 8M |
| Weighted average shares, diluted | 16M | 13M | 10M | 8M | 8M |
| Metric | 31 Mar 2026 | 31 Dec 2025 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 31 Jan 2025 | 31 Dec 2024 | 30 Sept 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 979,534 | 2M | 7M | 9M | 250,342 | — | 3,455 | 26,571 |
| Short-term investments | 2M | 2M |
| Metric | 31 Mar 2026 | 31 Mar 2025 |
|---|---|---|
| Operating cash flow | −2M | −20,313 |
| Depreciation and amortisation | 20,044 | — |
| Capital expenditure | 9,394 | — |
| Investing cash flow | 490,606 | — |
| Financing cash flow | 920,000 | 267,200 |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| — |
| — |
| — |
| — |
| — |
| — |
| Current assets | 13M | 14M | 9M | 10M | 259,904 | — | 13,057 | — |
| Property, plant and equipment | 56,592 | 51,626 | 34,188 | 13,137 | — | — | — | — |
| Total assets | 141M | 164M | 9M | 11M | 259,904 | — | 13,057 | — |
| Current liabilities | 15M | 11M | 1M | 809,002 | 2M | — | 1M | — |
| Total liabilities | 15M | 11M | 1M | 809,002 | 2M | — | 1M | — |
| Equity | 127M | 153M | 8M | 10M | −2M | — | −1M | −1M |
| Shares outstanding | 13M | 13M | 13M | 13M | 8M | 1 | 8M | — |
| Shares issued | 13M | 13M | 13M | 13M | 8M | 1 | 8M | — |